Results of a new study show that major weight loss has the same impact on diabetes remission whether through weight loss surgery or diet. In this Q&A, lead researcher Samuel Klein, MD, answers our...
Consultant360 spoke with lead author Greg Kinney, PhD, about his study, which found that cannabis use may be associated with an increased risk for diabetic ketoacidosis in patients with type 1 diabetes.
...
In this Q&A, Sara Reece, PharmD, CDCES, discusses the use of GLP-1 agonists and SGLT-2 inhibitors to improve cardiovascular and renal outcomes in patients with type 2 diabetes.
We spoke with Gilad Twig, MD, PhD, whose recent study indicates that resolved acute pancreatitis during childhood may be a risk factor for incident diabetes in adulthood.
Christianne Roumie, MD, MPH, answers our questions about her new study, which compared the incidence of diabetes and impaired fasting glucose among participants from the SPRINT Randomized Trial.
In a recent study, researchers assessed the relationship and resulting impact of exercise capacity on all-cause mortality risk among people with type 2 diabetes. Lead study author Yun-Ju Lai, MD, discussed...
Aveni Haynes, PhD, discusses findings from her new study, which suggested that improvements in HbA1c and decreases in severe hypoglycemia rates have occurred concurrently over the past 2 decades in the...
David C. Lee, MD, answered our questions about his new study, which indicated that an intervention involving rapid point-of-care HbA1c testing in barbershops could help identify undiagnosed diabetes and...
Endocrinology Consultant spoke with Derek LeRoith, MD, PhD, member of the task force that developed the Endocrine Society’s 2019 clinical practice guideline for the treatment of diabetes in older adults.
...
Endocrinology Consultant spoke with Christian Hampp, PhD, from the US Food and Drug Administration, whose study found high rates of diabetic ketoacidosis when sodium-glucose cotransporter 2 inhibitors are...
